Top Seattle, WA Health Tech Companies With Best Stability & Growth (206)
Headway’s mission is a big one – to build a new mental health care system everyone can access. We’ve built technology that helps people find great therapists with the first software-enabled national network of providers accepting insurance. 1 in 4 people in the US have a treatable mental health condition, but the majority of providers don’t accept insurance, making therapy...
Headway's Top Stability & Growth Strengths
Investor Backing & Capital Strength: Capital raises and valuation step‑ups are prominent, including a $100M Series D in July 2024 at a reported $2.3B valuation to fund expansion into Medicare Advantage and Medicaid. Independent coverage and company materials corroborate the round and use of proceeds.
Market Expansion: Nationwide availability (all 50 states + D.C.) and moves into Medicare Advantage (targeted 51 markets by end‑2024) with Medicaid launches planned for 2025 broaden the addressable market. Company updates indicate these government lines are now active in select states.
Strategic Partnerships: Payer connectivity has accelerated from roughly 40 to 70+ plans with preferred‑network status at major carriers, and revenue scales with completed sessions rather than sign‑ups. These relationships underpin growing patient access and utilization.
Who We Are Chewy is where pet parents find everything they need for life with pets, from food to fun to pharmacy. We make pet care easier, more informed, and more joyful through fast, reliable delivery and award-winning 24/7 Customer Care, including access to pet health support when it’s needed. Founded in 2011, Chewy combines the convenience of online shopping with...
Chewy's Top Stability & Growth Strengths
Profitability: Profitability is rising, with record quarterly profit, expanding margins, and stronger free cash flow highlighted across recent periods. Management also points to ongoing margin expansion alongside continued growth.
Strong Market Position & Advantage: Market position is characterized as a top player in U.S. online pet supplies, with ongoing share gains and leadership among pet‑specialty pure plays. A large subscription-driven base reinforces this advantage across consumables and health categories.
Resilient & Sustainable Growth: Growth is steady rather than explosive, with revenue and active customers continuing to expand and a recurring Autoship mix underpinning predictability. Expansion into pet health services and clinics is positioned to support durable, ecosystem-led growth.
We're Mochi Health, a pioneering force in obesity medicine dedicated to building personalized, clinically-backed weight care solutions. We're on a mission to empower patients with one-on-one virtual care and proven pharmaceutical treatments. We recognize that every body is unique, and believe weight loss plans should be, too. With over 100 million individuals struggling with obesity and 15 million already using GLP-1 prescriptions,...
Mochi Health's Top Stability & Growth Strengths
Market Expansion: Nationwide availability is promoted on care pages and the iOS App Store listing, indicating coverage in all 50 states and signaling continued geographic reach. Hiring signals and a move into a larger office further suggest expanding operational presence.
Innovation-Driven Growth: Recent product updates—Spanish-language app support and an EHR-integrated AI medical scribe announced in June–July 2026—show ongoing investment in platform capabilities. The cadence of dated releases points to active development and product velocity.
Diversified Revenue Streams: The launch of insurance-based, in‑network plans (announced May 20, 2025; page updated July 14, 2026) reflects movement beyond a cash‑pay model. This expansion of payer channels indicates efforts to broaden how revenue is generated.
Artera is an agentic company strengthening how healthcare providers communicate and care for patients. As an agentic partner, we bring over a decade of healthcare experience to address urgent workflows from day one and build custom solutions as healthcare providers’ needs evolve. Trusted by 1,000+ specialties, FQHCs, health systems, and federal agencies, Artera strengthens and enhances patient relationships across every...
Artera's Top Stability & Growth Strengths
Strong Revenue Growth: Reported $100M in contracted annual recurring revenue by year-end 2025 and rising platform activity indicate accelerating topline momentum. Expanding adoption of AI agents and larger-scale deployments point to growing recurring demand.
Investor Backing & Capital Strength: A $65M growth investment announced in December 2025 provides fresh capital to accelerate expansion and adoption of the platform. Participation from existing investors underscores continued access to funding for scale initiatives.
Market Expansion: FedRAMP Class D authorization for a Federal Edition opens pathways into U.S. federal healthcare settings. Materials citing 1,000+ provider organizations and deep EHR ecosystem integrations reflect broad and widening market reach.
ZS is a management consulting and technology firm that partners with companies to improve life and how we live it. We transform ideas into impact by bringing together data, science, technology and human ingenuity to deliver better outcomes for all. Founded in 1983, ZS has more than 15,000+ employees in over 40 offices worldwide.
ZS's Top Stability & Growth Strengths
Product Line Growth: The launch of a dedicated Platform & Products unit and expansions of the ZAIDYN platform (including new agentic‑AI suites) indicate a deliberate shift toward scalable, productized offerings. These moves suggest expanding monetization levers beyond traditional consulting.
Market Expansion: Headcount and office count have risen, with a global footprint now spanning 40+ locations and new capacity in Hyderabad and Chicago. Inorganic moves such as the acquisition of Salesforce specialist Torrent Consulting extend reach in key healthcare cloud markets.
Strong Market Position & Advantage: Consistent Leader placements by Everest Group and IDC across life‑sciences and analytics services point to competitive strength in core domains. This positioning aligns with indications of healthy demand for ZS’s specialized offerings.
Our purpose ensures that patients remain at the center of all we do. We live our purpose by sourcing the best science in the world; partnering with others in the healthcare system to improve access to our medicines; using digital technologies to enhance our drug discovery and development, as well as patient outcomes; and leading the conversation to advocate for...
Pfizer's Top Stability & Growth Strengths
Product Line Growth: Launched and acquired products are scaling, with oncology assets from the Seagen deal and brands such as Padcev, oncology biosimilars, Nurtec, Lorbrena, Abrysvo, Eliquis, and the Vyndaqel family cited as key contributors. Early‑2026 updates describe a meaningful uptick from these newer and in‑line medicines.
Innovation-Driven Growth: Management highlights a robust late‑stage pipeline with numerous pivotal study starts planned in 2026 and catalysts across oncology, vaccines, and metabolic disease. Programs such as an ADC (sigvotatug vedotin) and a GLP‑1 RA (berobenatide) are positioned to convert into future approvals and launches.
Diversified Revenue Streams: Growth beneath the surface is coming from multiple non‑COVID franchises rather than a single product, spanning oncology (including Seagen’s ADCs), vaccines, neurology, and cardiovascular. This breadth is helping to offset normalization in COVID‑related sales.
Grow is a mental health platform built to enable progress. We see technology not as a layer on top of care, but as the connective tissue that helps it grow — and we believe that building it is some of the most important work there is. We are not only for crisis. We are for all the moments when someone decides...
Grow Therapy's Top Stability & Growth Strengths
Investor Backing & Capital Strength: Significant late-stage financing, including an $88M Series C (April 2024) and a $150M Series D (March 2026) at a reported ~$3B valuation, is presented as fuel for continued scale. These rounds are explicitly tied to expanding product capabilities, the provider network, and payer/employer channels.
Strategic Partnerships: Expanded collaborations are highlighted, including a June 2026 research partnership with Stanford and broad access via 125+ insurer relationships, with added employer and health‑system programs (e.g., EAP‑to‑insurance continuity, Amazon, Circle Medical). These linkages signal deeper distribution and credibility across stakeholders.
Market Expansion: Operational reach appears to be widening through national payer coverage (including Medicare/Medicaid), employer routes, and health‑system integrations alongside a provider network cited around 26,000. Utilization markers such as 7M visits in 2025 and active hiring/office expansion indicate scaling across markets.
ISB is a collaborative and cross-disciplinary non-profit biomedical research organization based in Seattle. We focus on some of the most pressing issues in human health, including brain health, cancer, sepsis and aging, as well as many chronic and infectious diseases.
MacroHealth's mission is to make buying and selling healthcare services simple and powerful. We provide a Marketplace-as-a-Service that enables Payers, Providers, and Health Market Partners to Optimize and Connect their unique healthcare ecosystems. Our Optimization solutions provide analytics and connectivity focused on optimizing healthcare pricing and payments. We provide health Payers with data enhancement, analytical tools, and market benchmarking to design...
After the problematic launch of HealthCare.gov, we were part of the tech surge that tackled the project's challenges. Working closely with government, contractors, and tech surge members, we were inspired by the care and dedication of the whole team and the progress we all made in a short time. With Corbalt, we're bringing the same spirit to building better digital...
Luna is a leading in-home, tech-enabled physical therapy platform that provides 1:1 personalized care. By shifting treatment from the clinic to the home, the company improves accessibility, convenience, and patient outcomes. Luna leverages proprietary technology like Auto-Charting® to streamline documentation for therapists, allowing them to focus on patient care. The company partners with major health systems and is covered by...
Twistle is a pathway automation tool that delivers the right message at the right time, keeping patients on track. It's configurable, easy to use, and secure. Our "Care Plan Automation" platform helps clinical teams streamline care pathways by automating follow-up and surveillance — all while delivering an incredible patient experience. Our mobile health tool connects providers and patients through secure automated...
Concord Technologies is a leading provider of secure document exchange, intelligent document processing, and interoperability solutions to healthcare providers, payers, and other highly regulated businesses. For over twenty years, billions of sensitive records containing valuable patient information have been reliably, accurately, and securely sent and received across Concord’s digital health network. Today, the company processes over five billion pages of...
LifeStance Health is a behavioral health care company focused on providing evidenced-based, medically driven treatment services for children, adolescents and adults suffering from a variety of mental health issues in care settings that include acute inpatient, partial hospitalization, intensive outpatient, outpatient, community-based and in-home. Our Vision: A truly healthy society where mental and physical healthcare are unified to make lives better....
_16.png)
Remote Medical International (RMI) is an experienced provider of comprehensive medical support services for customers operating in remote and challenging locations worldwide.
Prescryptive Health is a digital health company focused on improving the prescription drug market.
Icosavax is focused on developing safe and effective vaccines against infectious diseases that cause severe, life-threatening respiratory illnesses. Icosavax is advancing VLP vaccine candidates against respiratory syncytial virus (RSV), human metapneumovirus (hMPV), and SARS-CoV-2 (COVID-19). These vaccine candidates have shown induction of high and durable neutralizing antibody titers in preclinical studies and could protect the most vulnerable populations, including older...
At Ryan Companies, we believe the value of the buildings we design, develop, finance, manage and construct is about more than dollars and cents – it’s also about the value they bring to the people who use them and the communities that surround them.
Cardiac Insight, Inc. is a privately held medical device company based in Seattle, WA. Cardiac Insight is developing advanced, body worn ECG sensing technology aimed at the early diagnosis of atrial fibrillation (AF) and other conditions. Earlier last year, the company announced a strategic collaboration with Welch Allyn, now part of the Hill-Rom family of companies, for the distribution rights...
Stasys Medical is a Seattle based company developing a system to rapidly identify blood clotting deficiencies and provide relevant, actionable information to caregivers. We are comprised of a passionate group of physicians, scientists and engineers with a diverse set of skills needed to positively impact the health care sector.
